Electrical impedance myography discriminates congenital muscular dystrophy from controls.
Daniel P Schwartz, Jahannaz Dastgir, Anam Salman...
https://pubmed.ncbi.nlm.nih.gov/26179210/Actively Recruiting
Led by National Institute of Neurological Disorders and Stroke (NINDS) · Updated on 2026-08-04
275
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying electrical impedance myography EIM, a new, painless technique that measures how a mild electrical current passes through muscles to evaluate neuromuscular disorders. The study includes both healthy volunteers and individuals with various neuromuscular diseases to compare EIM results with standard tests. The goal is to understand if EIM can differentiate types of neuromuscular disorders and to establish reproducible, normative values across different ages and populations. Participants will undergo testing using the EIM device, which involves placing electrodes on the skin to deliver a high-frequency current. Additional tests may include nerve and muscle ultrasonography, nerve conduction studies, and electromyography EMG with a thin needle for adults. Testing sessions typically last up to three hours, with healthy volunteers and patients possibly returning for follow-up visits to assess reproducibility and monitor changes over time. Participants will have one or more clinic visits involving medical history, physical exams, and various muscle and nerve assessments. Researchers will collect data on EIM measures, ultrasound, and other electrodiagnostic methods to evaluate their relationships and utility. The study aims to track changes in specific parameters over time, especially in pediatric patients, with a total study duration extending up to 10 years. Safety and comfort are prioritized, and the procedures are noninvasive or minimally invasive.
CONDITIONS
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
C
Candida C Silva
T
Tanya J Lehky, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Neurological Disorders and Stroke (NINDS)
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational: EIM plus ultrasound, nerve conduction studies, EMG | Standard diagnostic combination: ultrasound, nerve conduction studies, EMG |
|---|---|---|
| What it is | A non-invasive diagnostic protocol combining EIM with neuromuscular ultrasound, nerve conduction studies, and EMG as evaluated in the trial | A combination of neuromuscular ultrasound, nerve conduction studies, and EMG routinely used to diagnose nerve and muscle disorders |
| Role in trial | Investigated diagnostic approach evaluated in all trial participants | Used as external reference standard outside trial |
| Primary use | Assess muscle condition and neuromuscular disease status as part of diagnostic work-up | Diagnose nerve and muscle conditions such as neuropathies, myopathies, and motor neuron disorders |
| How it is done | EIM device placed on muscle delivering high‑frequency current along with ultrasound imaging and electrodiagnostic tests. | Ultrasound provides real‑time imaging of muscles and nerves; nerve conduction uses surface electrodes to assess signal speed; EMG records muscle electrical activity via needle electrodes. |
| Evidence status | Investigational; evidence under collection in natural history study without established diagnostic accuracy | Established diagnostic tools widely used with accepted clinical validity |
| Important limitations | Diagnostic performance of EIM is not yet established and it adds complexity to the evaluation protocol | Ultrasound and electrodiagnostic tests may require skilled operators and may be uncomfortable for participants |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 to 3 hours per session
Participants undergo testing with the EIM device and may also have ultrasound, nerve conduction studies, and for adults, electromyography with a thin needle. These tests assess muscle and nerve function.
1 visit with possible follow-up visits
Duration - Up to 2 years for pediatric follow-up
Some participants, especially pediatric patients, may return for additional visits to monitor changes over time and assess reproducibility of test results.
Additional visits as needed
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Daniel P Schwartz, Jahannaz Dastgir, Anam Salman...
https://pubmed.ncbi.nlm.nih.gov/26179210/Carmel Nichols, Minal S Jain, Katherine G Meilleur...
https://pubmed.ncbi.nlm.nih.gov/28224647/Michelle B Offit, Tianxia Wu, Mary Kay Floeter...
https://pubmed.ncbi.nlm.nih.gov/32312103/National Institute of Neurological Disorders and Stroke (NINDS)
Lead Sponsor